EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Developments in Aptamer-Based Sensors for Diagnostics

Muhammad Sheraz iD, Xiao-Feng Sun iD, Yongke Wang iD, Jiayi Chen, Le Sun

Sensors · 21.11.2024 · 24 (23) · 7432

DOI: 10.3390/s24237432 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Sensors, online erschienen am 21.11.2024. Verfasst von Muhammad Sheraz und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Northwestern Polytechnical University, Xi'an 710072, China. Hauptthemen laut MEDLINE: Biosensing Techniques, Aptamers, Nucleotide, SELEX Aptamer Technique. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D project of Shaanxi Province, Xi'an Science and Technology Plan Project, Shenzhen Science and Technology Project for Sustainable Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic and non-communicable diseases (NCDs) account for a large proportion of global disorders and mortality, posing significant burdens on healthcare systems. Early diagnosis and timely interference are critical for effective management and disease prevention. However, the traditional methods of diagnosis still suffer from high costs, time delays in processing, and infrastructure requirements that are usually unaffordable in resource-constrained settings. Aptamer-based biosensors have emerged as promising alternatives to offer enhanced specificity, stability, and cost-effectiveness for disease biomarker detection. The SELEX (Systematic Evolution of Ligands by Exponential Enrichment) methodology allows developing aptamers with high-affinity binding capabilities to a variety of targets, for instance proteins, cells, or even small molecules, hence rendering them suitable for NCD diagnosis. Aptasensors—recent developments in the electrochemical and optical dominion—offer much enhanced sensitivity, selectivity, and stability of detection across a diverse range of diseases from lung cancer and leukemia to diabetes and chronic respiratory disorders. This study provides a comprehensive review of progress in aptamer-based sensors, focusing on their role in point-of-care diagnostics and adaptability in a real-world environment with future directions in overcoming current limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesAptamers, NucleotideSELEX Aptamer TechniqueHumansElectrochemical TechniquesBiomarkersPoint-of-Care Systems

Stichwörter der Autor:innen

SELEXaptamer-based biosensorschronic and non-communicable diseasespoint-of-care diagnostics

Substanzen

Aptamers, NucleotideBiomarkers

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Northwestern Polytechnical University, Xi'an 710072, China.

ORCID-Profile: Muhammad Sheraz, Xiao-Feng Sun, Yongke Wang

Förderung

  • Key R&D project of Shaanxi Province
  • Xi'an Science and Technology Plan Project
  • Shenzhen Science and Technology Project for Sustainable Development
  • Northwestern Polytechnical University Education and Teaching Reform Research Project
  • Key R&D project of Shaanxi Province
  • Xi’an Science and Technology Plan Project

Zitieren

APA

Sheraz, M., Sun, X. F., Wang, Y., Chen, J., & Sun, L. (2024). Recent Developments in Aptamer-Based Sensors for Diagnostics. Sensors, 24(23), 7432. https://doi.org/10.3390/s24237432

Vancouver

Sheraz M, Sun XF, Wang Y, Chen J, Sun L. Recent Developments in Aptamer-Based Sensors for Diagnostics. Sensors. 2024;24(23):7432. doi:10.3390/s24237432

BibTeX
@article{Sheraz2024,
  author = {Sheraz, Muhammad and Sun, Xiao-Feng and Wang, Yongke and Chen, Jiayi and Sun, Le},
  title = {Recent Developments in Aptamer-Based Sensors for Diagnostics},
  journal = {Sensors},
  year = {2024},
  volume = {24},
  number = {23},
  pages = {7432},
  doi = {10.3390/s24237432}
}
Kostenlos starten →